Vedika Mehra
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCL.
Journal: Molecular therapy. Advances
Published: February 13, 2025
CAR-T Cell Therapy for PTLD: Analysis of CAR-T Product, Engraftment, and Outcomes in Patients Receiving Parallel Immunosuppression.
Journal: EJHaem
Published: August 21, 2024
Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy.
Journal: Cancers
Published: January 22, 2024
The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics.
Journal: Biology
Published: September 07, 2023
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival.
Journal: Journal for immunotherapy of cancer
Published: July 27, 2023
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 31, 2021
Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation.
Journal: Frontiers in immunology
Published: April 08, 2020
Bone marrow mesenchymal stem cells do not enhance intra-synovial tendon healing despite engraftment and homing to niches within the synovium.
Journal: Stem cell research & therapy
Published: January 09, 2018
Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.
Journal: Histochemistry and cell biology
Published: May 24, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026